Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered Steroidogenesis
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
P450 oxidoreductase (POR) is the obligatory flavoprotein intermediate that transfers electrons from reduced nicotinamide adenine dinucleotide phosphate (NADPH) to all microsomal cytochrome P450 enzymes. Although mouse Por gene ablation causes embryonic lethality, POR missense mutations cause disordered steroidogenesis, ambiguous genitalia, and Antley-Bixler syndrome (ABS), which has also been attributed to fibroblast growth factor receptor 2 (FGFR2) mutations. We sequenced the POR gene and FGFR2 exons 8 and 10 in 32 individuals with ABS and/or hormonal findings that suggested POR deficiency. POR and FGFR2 mutations segregated completely. Fifteen patients carried POR mutations on both alleles, 4 carried mutations on only one allele, 10 carried FGFR2 or FGFR3 mutations, and 3 patients carried no mutations. The 34 affected POR alleles included 10 with A287P (all from whites) and 7 with R457H (four Japanese, one African, two whites); 17 of the 34 alleles carried 16 "private" mutations, including 9 missense and 7 frameshift mutations. These 11 missense mutations, plus 10 others found in databases or reported elsewhere, were recreated by site-directed mutagenesis and were assessed by four assays: reduction of cytochrome c, oxidation of NADPH, support of 17alpha-hydroxylase activity, and support of 17,20 lyase using human P450c17. Assays that were based on cytochrome c, which is not a physiologic substrate for POR, correlated poorly with clinical phenotype, but assays that were base…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas most genetically determined craniosynostosis is characterised by dominant inheritance, Antley-Bixler syndrome (features include disordered sex development and radio-humeral synostosis; mutation in POR encoding cytochrome P450 oxidoreductase) 35 and Carpenter syndrome (with polysyndactyly; mutation in RAB23 encoding RAB23, member of RAS oncogene family) 36 are recessive disorders.”
From Craniosynostosis (2011) · cites this paper as [35]
In the citing paper
“These mutations demonstrate pathogenic roles for steroid metabolism and hedgehog (or possibly Wnt) signalling in cranial suture development, both of which are at present poorly understood.”
From Craniosynostosis (2011) · cites this paper as [35]
In the citing paper
“POR is located in the endoplasmic reticulum of the cells, where it operates as an electron donor for the cytochromes P450, heme oxygenase, squalene monooxygenase, and other redox partners [2,3,4].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [4]
In the citing paper
“Considering all available data from previous reports [4,46,47] and multiple functional assays described in this manuscript, we suggest that rs17853284, the variant causing amino acid change P228L in POR, is a disease-causing variant, whose effect will be prominent when present together with another variant of POR on the second allele that has a severe impact on POR activities.”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [4]
In the citing paper
“Before our study only two p.A287P homozygous patients have been described; one with an unclear karyotype and genital appearance (7) and the other with ambiguous genitalia and 46,XY DSD (3).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [7]
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · cited 2×
“The POR sequences from human, rat, Xenopus, Drosophila, and yeast were aligned with ClustalW (Thompson et al. 1994), and sequences were displayed and ed-”
MethodComparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Modeling of loops in protein structures
Fiser, A., Do, R. K. G., & Šali, A. (2000) · Protein Science · doi:10.1110/ps.9.9.1753 · Cited by 2,116 · cited 1×
“Molecular modeling of human POR was performed by MODELLER (Sali and Blundell 1993; Fiser et al. 2000), which uses satisfaction of spatial restraints for comparative modeling of proteins.”
MethodMiroux, B., & Walker, J. E. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0399 · Cited by 1,959
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935
Self-citationOnline Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 758
Self-citationWang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Redesign of the coenzyme specificity of a dehydrogenase by protein engineering
Scrutton, N. S., Berry, A., & Perham, R. N. (1990) · Nature · doi:10.1038/343038a0 · Cited by 730
The extinction coefficient of cytochrome c
Van Gelder, B. F., & Slater, E. C. (1962) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(62)90073-2 · Cited by 696
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692 · cited 2×
“…and Kasper 1995; Estabrook et al. 1996; Wang et al. 1997), whereas the redox-partner-binding site of microsomal P450 enzymes is typically characterized by basic residues (Hasemann et al. 1995; Fisher et al. 1996; Geller et al. 1997; Auchus and Miller 1999; Kondo et al. 1999; Davydov et al. 2000).”
BackgroundA common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614 · cited 2×
“Work in the 1990s showed that four phenotypically related craniosynostosis syndromes—Apert, Crouzon, Jackson-Weiss, and Pfeiffer syndromes—were caused by mutations in the gene for fibroblast growth factor receptor 2 (FGFR2) (Jabs et al. 1994; Muenke et al. 1994; Reardon et al. 1994; Gorry et al. 1995; Park et al. 1995…”
BackgroundSelf-citationLu, A. Y. H., Junk, K. W., & Coon, M. J. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83427-5 · Cited by 577
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationKarplus, P. A., Daniels, M. J., & Herriott, J. R. (1991) · Science · doi:10.1126/science.1986412 · Cited by 536
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 27×
“R457H was also found on 1 of 2 Jap- Huang et al.: P450 Oxidoreductase Deficiency 739 anese alleles in our initial study (Flück et al. 2004) and on 2 of 4 alleles (Adachi et al. 2004) and 10 of 16 alleles (Fukami et al. 2005) in two recent studies of Japanese patients.”
BackgroundMethodResultInfluentialSelf-citationJabs, E. W., Li, X., Scott, A. F., Meyers, G., Chen, W., Eccles, M., Mao, J.-I., Charnas, L. R., Jackson, C. E., & Jaye, M. (1994) · Nature Genetics · doi:10.1038/ng1194-275 · Cited by 468
Self-citationZhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Self-citationThe backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347 · cited 2×
“Alternatively, it has been suggested that increased androgen synthesis through an alternative “backdoor” pathway (Auchus 2004) may result in the virilization of mothers carrying a POR-deficient fetus (Arlt et al.”
BackgroundArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345 · cited 10×
“Alternatively, it has been suggested that increased androgen synthesis through an alternative “backdoor” pathway (Auchus 2004) may result in the virilization of mothers carrying a POR-deficient fetus (Arlt et al. 2004), but definitive data are lacking.”
BackgroundMethodInfluentialAnalysis of enzyme kinetic data
(1995) · Biochemical Education · doi:10.1016/0307-4412(95)90181-7 · Cited by 324
Novel Lipid Modifications of Secreted Protein Signals
Mann, R. K., & Beachy, P. A. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073933 · Cited by 322
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318 · cited 11×
“In this system, a yeast strain lacking the gene for yeast POR was transiently transfected with vectors expressing human P450c17 and POR (Auchus et al. 1998).”
BackgroundMethodInfluentialSelf-citationCognitive and behavior profile of preschool children with chromosome 22q11.2 deletion
Gerdes, M., Solot, C., Wang, P. P., Moss, E., LaRossa, D., Randall, P., Goldmuntz, E., Clark, B. J., Driscoll, D. A., Jawad, A., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990716)85:2<127::aid-ajmg6>3.0.co;2-f · Cited by 290
Self-citationShen, A. L., Porter, T. D., Wilson, T. E., & Kasper, C. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83274-4 · Cited by 264
Analysis of phenotypic features and FGFR2 mutations in Apert syndrome.
Park, W. J., Theda, C., Maestri, N. E., Meyers, G. A., Fryburg, J. S., Dufresne, C. R., Cohen, M. M., & Jabs, E. W. (1995) · PubMed Central · Cited by 259
Self-citationHenderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212087200 · Cited by 258
Fluconazole-induced congenital anomalies in three infants
Pursley, T. J., Blomquist, I. K., Abraham, J., Andersen, H. F., & Bartley, J. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.336 · Cited by 246
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome
Schell, U., Hehr, A., Feldman, G. J., Robin, N. H., Zackai, E. H., de Die-Smulders, C., Viskochil, D. H., Stewart, J. M., Wolff, G., Ohashi, H., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.3.323 · Cited by 234
von Heijne, G. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02132.x · Cited by 231
Shen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225 · cited 3×
“2003), whereas the global Por-knockout mouse is embryonic lethal (Shen et al. 2002; Otto et al. 2003).”
BackgroundEswarakumar, V. P., Horowitz, M. C., Locklin, R., Morriss-Kay, G. M., & Lonai, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405031101 · Cited by 224
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214 · cited 1×
“…al. 2003), apparently due to disruption of extrahepatic P450 enzymes, as liver-specific knockout of Por yields phenotypically and reproductively normal mice that accumulate hepatic lipids and have a remarkably diminished capacity for hepatic drug metabolism (Gu et al. 2003; Henderson et al. 2003).”
BackgroundcDNA sequence of adrenodoxin reductase: Identification of NADP‐binding sites in oxidoreductases
HANUKOGLU, I., & GUTFINGER, T. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14671.x · Cited by 196
Cytochrome P450: What Have We Learned and What Are the Future Issues?
Peter Guengerich, F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120033996 · Cited by 193
Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes
Herman, G. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg072 · Cited by 190
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189 · cited 4×
“Similarly, Otto et al. (2003) suggested that the phenotype might be associated with decreased activity of CYP26, which degrades retinoids; decreasing the retinoic acid in the diets of pregnant mice carrying Por-knockout fetuses partially ameliorated the phenotype.”
BackgroundInfluentialFibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome
Przylepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-492 · Cited by 185
Self-citationAuchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Self-citationGeller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183 · cited 8×
“In this system, a yeast strain lacking the gene for yeast POR was transiently transfected with vectors expressing human P450c17 and POR (Auchus et al. 1998).”
BackgroundMethodInfluentialSelf-citationLin, D. (1993) · Endocrinology · doi:10.1210/en.132.6.2498 · Cited by 175
Self-citationPark, W.-J., Meyers, G. A., Li, X., Theda, C., Day, D., Oriow, S. J., Jones, M. C., & Jabs, E. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.7.1229 · Cited by 172
Self-citationYanagibashi, K., & Hall, P. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83930-3 · Cited by 171
Meyers, G. A., Day, D., Goldberg, R. B., Daentl, D. L., Przylepa, K. A., Abrams, L., Graham, J., Feingold, M., Moeschler, J. B., Rawnsley, E. F., et al. (1996) · PubMed Central · Cited by 168
Self-citationClinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency
Miller, W. L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.241 · Cited by 167
Clinical review 54: Genetics, diagnosis, and management of 21- hydroxylase deficiency
Miller, W. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106606 · Cited by 165
Self-citationSolubilization and partial characterization of rat liver squalene epoxidase
Ono, T., & Bloch, K. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41847-4 · Cited by 157
Arlt, W., Auchus, R. J., & Miller, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100040200 · Cited by 157 · cited 2×
“This system was originally developed to assay P450c17 activities: the transfected human POR was abundant and not limiting, and the amount of P450c17 was measured by difference spectra, yielding reproducible measures of P450c17 enzymology (Auchus et al. 1998; Arlt et al. 2001), but the ratio of P450c17”
MethodSelf-citationFukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155 · cited 2×
“R457H was also found on 1 of 2 Jap- Huang et al.: P450 Oxidoreductase Deficiency 739 anese alleles in our initial study (Flück et al. 2004) and on 2 of 4 alleles (Adachi et al. 2004) and 10 of 16 alleles (Fukami et al. 2005) in two recent studies of Japanese patients.”
BackgroundPeterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17
Pandey, A. V., Mellon, S. H., & Miller, W. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209527200 · Cited by 137 · cited 1×
“1998; Auchus and Miller 1999; Pandey et al. 2003).”
BackgroundSelf-citationShen, A. L., & Kasper, C. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27475 · Cited by 136
Missense mutation serine106—-proline causes 17 alpha-hydroxylase deficiency
Lin, D., Harikrishna, J. A., Moore, C. C., Jones, K. L., & Miller, W. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98506-6 · Cited by 135 · cited 1×
“Steroids from different reactions were spotted on silica gel 60 F254 thin-layer chromatography (TLC) plates (Merck) and were developed with ethyl acetate:chloroform (3: 1) (Lin et al. 1991).”
MethodSelf-citationAntley, R. M., & Bixler, D. (1975) · PubMed · Cited by 128
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123
Self-citationAdachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K., & Oka, A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30169 · Cited by 110 · cited 5×
“R457H was also found on 1 of 2 Jap- Huang et al.: P450 Oxidoreductase Deficiency 739 anese alleles in our initial study (Flück et al. 2004) and on 2 of 4 alleles (Adachi et al. 2004) and 10 of 16 alleles (Fukami et al. 2005) in two recent studies of Japanese patients.”
BackgroundInfluentialAbnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia
Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Miller Wolf, L., & Jabs, E. W. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10510 · Cited by 95
Self-citationNadler, S. G., & Strobel, H. W. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90358-x · Cited by 91
Gorry, M. C., Preston, R. A., White, G. J., Zhang, Y., Singhal, V. K., Losken, H. W., Parker, M. G., Nwokoro, N. A., Post, J. C., & Ehrlich, G. D. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1387 · Cited by 91
Miller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
Self-citationPulleyn, L. J., Reardon, W., Wilkes, D. C., Rutland, P., Jones, B. M., Hayward, R. D., Hall, C. M., Brueton, L. A., Chun, N., Lammer, E. J., et al. (1996) · European Journal of Human Genetics · doi:10.1159/000472215 · Cited by 80
Self-citationMulrooney, S. B., & Waskell, L. A. (2000) · Protein Expression and Purification · doi:10.1006/prep.2000.1228 · Cited by 77
Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III
Gripp, K. W., Stolle, C. A., McDonald-McGinn, D. M., Markowitz, R. I., Bartlett, S. P., Katowitz, J. A., Muenke, M., & Zackai, E. H. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980724)78:4<356::aid-ajmg10>3.0.co;2-h · Cited by 76
Wu, L., Gu, J., Cui, H., Zhang, Q.-Y., Behr, M. J., Fang, C., Weng, Y., Kluetzman, K., Swiatek, P. J., Yang, W., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073353 · Cited by 71
Conditional knockout of the mouse NADPH‐cytochrome p450 reductase gene
Wu, L., Gu, J., Weng, Y., Kluetzman, K., Swiatek, P., Behr, M., Zhang, Q., Zhuo, X., Xie, Q., & Ding, X. (2003) · genesis · doi:10.1002/gene.10214 · Cited by 68
Antley-Bixler syndrome: Case report and review of the literature
CRISPONI, G., PORCU, C., & PIU, M. E. (1997) · Clinical Dysmorphology · doi:10.1097/00019605-199701000-00011 · Cited by 65
Davydov, D. R., Kariakin, A., Petushkova, N. A., & Peterson, J. A. (2000) · Biochemistry · doi:10.1021/bi992936u · Cited by 64
Haniu, M., McManus, M. E., Birkett, D. J., Lee, T. D., & Shively, J. E. (1989) · Biochemistry · doi:10.1021/bi00447a054 · Cited by 63
Mechanistic Studies on the Reductive Half-reaction of NADPH-Cytochrome P450 Oxidoreductase
Shen, A. L., Sem, D. S., & Kasper, C. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5391 · Cited by 63
Dierks, E. A., Davis, S. C., & Ortiz de Montellano, P. R. (1998) · Biochemistry · doi:10.1021/bi972458s · Cited by 59
Estabrook, R. W., Shet, M. S., Fisher, C. W., Jenkins, C. M., & Waterman, M. R. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0395 · Cited by 58
Kress, W., Petersen, B., Collmann, H., & Grimm, T. (2000) · Cytogenetic and Genome Research · doi:10.1159/000056834 · Cited by 57
Okajima, K., Robinson, L. K., Hart, M. A., Abuelo, D. N., Cowan, L. S., Hasegawa, T., Maumenee, I. H., & Jabs, E. W. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990716)85:2<160::aid-ajmg11>3.0.co;2-r · Cited by 57
Self-citationNadler, S. G., & Strobel, H. W. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90542-q · Cited by 55
Haniu, M., Iyanagi, T., Legesse, K., & Shively, J. E. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89802-7 · Cited by 50
NADPH-cytochrome P-450 oxidoreductase. The role of cysteine 566 in catalysis and cofactor binding.
Shen, A. L., Christensen, M. J., & Kasper, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54879-1 · Cited by 44
Shen, A. L., & Kasper, C. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m008380200 · Cited by 43
The syndrome of multisynostotic osteodysgenesis with long‐bone fractures
Delozier, C. D., Antley, R. M., Williams, R., Green, N., Heller, R. M., Bixler, D., Engel, E., & Optiz, J. M. (1980) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320070322 · Cited by 43
Antley‐Bixler syndrome: report of a patient and review of literature
Hassell, S., & Butler, M. G. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04182.x · Cited by 42
Cytochrome P-450: Cytochrome P-450 Reductase Interactions
Strobel, H. W., Nadler, S. G., & Nelson, D. R. (1989) · Drug Metabolism Reviews · doi:10.3109/03602538909103558 · Cited by 38
Congenital adrenal hyperplasia
(1986) · New England Journal of Medicine · doi:10.1056/nejm198605153142015 · Cited by 36
Roman, L. J., McLain, J., & Masters, B. S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212309200 · Cited by 35
Fisher, C., Shet, M. S., & Estabrook, R. W. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)72004-9 · Cited by 32
Shen, A. L., & Kasper, C. B. (1996) · Biochemistry · doi:10.1021/bi960587n · Cited by 31
Kondo, S., Sakaki, T., Ohkawa, H., & Inouye, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0455 · Cited by 30
Features of Antley-Bixler syndrome in an infant born to a mother with pregnancy luteoma
Roth, C., Hinney, B., Peter, M., Steinberger, D., & Lakomek, M. (2000) · European Journal of Pediatrics · doi:10.1007/s004310050048 · Cited by 28
Warmann, S. W., Roth, C. L., Glüer, S., & Fuchs, J. (2000) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(00)90232-x · Cited by 23
Genetically engineered yeast cells and their applications
Pompon, D., Perret, A., Bellamine, A., Lainé, R., Gautier, J., & Urban, P. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03522-2 · Cited by 22
Antley-Bixler syndrome with radioulnar synostosis
Hurley, M. E., White, M., Green, A., & Kelleher, J. (2004) · Pediatric Radiology · doi:10.1007/s00247-003-1066-7 · Cited by 21
Ambiguous genitalia due to partial activity of cytochromes P450c17 and P450c21
Augarten, A., Pariente, C., Gazit, E., Chayen, R., Goldfarb, H., & Sack, J. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90222-5 · Cited by 16 · cited 5×
“Patient 32 (ISRL1), who has been described elsewhere (Augarten et al. 1992), was the 46,XY, 2,620-g, 48-cm product of a 38-wk pregnancy; the patient had no dysmorphic features suggestive of ABS but had a 1-cm microphallus, a bifid scrotum, glandular hypospadias, and bilaterally palpable testes.”
BackgroundInfluentialSelf-citationUnilateral terminal aphalangia in father and daughter?exogenous or genetic cause?
Neumann, L. M., Pelz, J., & Kunze, J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980724)78:4<319::aid-ajmg3>3.0.co;2-g · Cited by 13
Kumar, D., & Masel, J. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02511.x · Cited by 9
Bilateral radial ray hypoplasia with multiple epiphyseal dysplasia
Eddy, M. C., Steiner, R. D., McAlister, W. H., & Whyte, M. P. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980518)77:3<219::aid-ajmg6>3.0.co;2-k · Cited by 8
Aleck (1997) · doi:10.1002/(sici)1096-8628(19971031)72:3<253::aid-ajmg1>3.0.co;2-s
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“In recent years rare POR missense mutations in humans were discovered that cause disordered steroidogenesis, ambiguous genitalia, and Antley–Bixler syndrome (Flück et al., 2004; Huang et al., 2005; Flück et al., 2008).”
BackgroundThe Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationYan, B., Ai, Y., Sun, Q., Ma, Y., Cao, Y., Wang, J., Zhang, Z., & Wang, X. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.024 · Cited by 617
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Self-citation
Metadata
- Authors
- Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Children's Health Ireland at Crumlin (IE)
- Hospital Universitario La Paz (ES)
- Sydney Children's Hospital (AU)
- Johns Hopkins University (US)
- Université de Montréal (CA)
- Tel Aviv University (IL)
- University Children’s Hospital Bern (CH)
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 76
- Issue
- 5
- Pages
- 729-749
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1199364
- OpenAlex
- W2062798854
- Semantic Scholar
- 892a16ff5112b5c86510eedcdee62d1812e75a79
- Cited by
- 336
- References
- 99
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 9 · 2020: 14 · 2019: 17 · 2018: 15 · 2017: 11 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 23 · 2012: 14
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3001 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM073020, R01GM73020)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK037922, K01DK002939, KO1 DK02939, R01DK37922)
- National Institute of Dental and Craniofacial Research (P60DE013078)
- National Center for Research Resources (M01 RR-00052, M01RR000052)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD41958, R01HD041958)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- cytochrome P450 oxidoreductase, Antley-Bixler syndrome, ambiguous genitalia, FGFR2 mutations, FGFR3 mutation, missense mutations, frameshift mutation, genotype-phenotype correlation, P450c17, 17α-hydroxylase, 17,20-lyase, NADPH oxidation, cytochrome c reduction
- MeSH terms
- Abnormalities, Multiple, Amino Acid Sequence, Craniosynostoses, Female, Genitalia, Humans, Infant, Infant, Newborn, Male, Models, Molecular, Molecular Sequence Data, Mutation, NADPH-Ferrihemoprotein Reductase, Steroids, Syndrome, Genetic Variation, Sequence Alignment, Receptors, Fibroblast Growth Factor, Receptor Protein-Tyrosine Kinases, Receptor, Fibroblast Growth Factor, Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.